TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
青光眼中的小梁网蛋白
基本信息
- 批准号:7884885
- 负责人:
- 金额:$ 19.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAuditoryBiologicalBlindnessBreedingCellsCochleaControl AnimalDepositionDisease ProgressionDown-RegulationExtracellular MatrixEyeEye diseasesFunctional disorderGenesGlaucomaGlycosaminoglycansGoalsHumanImmunohistochemistryInjection of therapeutic agentKnock-outLentivirus VectorMeasurementMessenger RNAMethodsModelingMolecularMusOptic NervePathogenesisPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProcessProteinsProteomicsRegulationResistanceRoleSiteSmall Interfering RNASymptomsTechniquesTestingTimeTissuesTrabecular meshwork structureViralVirus Diseasesaqueousbasecongeniceffective therapymouse modelnoveloptic nerve disorderpreventsmall hairpin RNA
项目摘要
Glaucoma refers collectively to a group of eye diseases whose molecular basis is poorly understood.
Worldwide primary open angle glaucoma (POAG) is one of the leading causes of blindness and is currently
incurable. Distinguishing symptoms of POAG are increased intraocular pressure (IOP) and glaucomatous
optic neuropathy. Increased resistance to aqueous outflow through the filtering trabecular meshwork (TM)
tissue appears to play a key role in the onset and progression of POAG. Blockage at the level of trabecular
meshwork leads to increased IOP. Proteomic and Western analyses of normal and glaucomatous TM have
revealed cochlin, a secreted protein with unknown function, present exclusively in glaucomatous but not in
normal TM. Subsequently we have also observed cochlin containing deposits by immunohistochemistry in
glaucomatous TM. In the human cochlea, cochlin is associated with mucopolysaccharide deposits in
progressive auditory dysfunction. In the TM, deposition of cochlin and mucopolysaccharides may interfere
with regulation of aqueous outflow and may cause slow but progressive elevation of IOP. We have extended
these studies to mice and found that cochlin levels were elevated in the DBA/2J model of glaucoma but not
in control animals. The studies proposed here will use mouse models to determine the role of cochlin in IOP
elevation. The central hypothesis to be tested is that cochlin deposits in the extracellular matrix obstruct
aqueous outflow in glaucomatous TM, elevate IOP and contribute to the pathogenesis of POAG. The long-
term goals of this project are to establish the mechanistic involvement of cochlin in IOP elevation and the
pathogenesis of POAG, and to develop effective therapies for preventing disease progression. Our
hypothesis will be tested with following specific aims: (1) To determine whether cochlin over-expression
results in elevated IOP; (2) To determine whether DBA/2J mice lacking cochlin maintain normal IOP; (3) To
test whether cochlin message down-regulation results in normal IOP in DBA/2J mouse. Methods will include
intraocular injections, IOP measurements, viral infections, immunohistochemisty as well as other molecular
and cell biological techniques.
青光眼集体指的是一组分子依据的眼科疾病。
全球初级敞开角度青光眼(POAG)是失明的主要原因之一,目前是
无法治愈。 POAG的区分症状是眼内压(IOP)和青光眼增加
视神经病变。通过过滤小梁网(TM)增加对水流的抗性
组织似乎在POAG的发作和进展中起关键作用。小梁水平的阻塞
网状工作导致IOP增加。正常和青光眼TM的蛋白质组学和西方分析
揭示的科克林是一种具有未知功能的分泌蛋白,仅在青光眼中存在,但不存在
正常TM。随后,我们还观察到Cochlin通过免疫组织化学的沉积物中的Cochlin
青光眼TM。在人耳蜗中,科克林与粘多糖沉积有关
进行性听觉功能障碍。在TM中,Cochlin和粘多糖的沉积可能会干扰
随着水性流出的调节,可能会导致IOP的缓慢而渐进的升高。我们已经扩展了
这些对小鼠的研究,发现在青光眼的DBA/2J模型中,科克林水平升高,但不是
在对照动物中。这里提出的研究将使用小鼠模型来确定Cochlin在IOP中的作用
海拔。要测试的中心假设是细胞外基质阻塞中的科克林沉积物
青光眼TM中的水流,提升IOP并有助于POAG的发病机理。长期
该项目的术语目标是确定科奇林在IOP高程中的机械参与和
POAG的发病机理,并开发有效的疗法来预防疾病进展。我们的
假设将以以下特定目的进行检验:(1)确定Cochlin是否过表达
导致IOP升高; (2)确定缺乏Cochlin的DBA/2J小鼠是否保持正常IOP; (3)到
测试Cochlin消息下调是否导致DBA/2J鼠标中的正常IOP。方法将包括
眼内注射,IOP测量,病毒感染,免疫组织化学以及其他分子
和细胞生物技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjoy K Bhattacharya其他文献
Sanjoy K Bhattacharya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjoy K Bhattacharya', 18)}}的其他基金
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
- 批准号:
10515332 - 财政年份:2020
- 资助金额:
$ 19.14万 - 项目类别:
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
- 批准号:
10308550 - 财政年份:2020
- 资助金额:
$ 19.14万 - 项目类别:
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts
促进 RGC 轴突再生的新目标:来自独特 RGC 队列的见解
- 批准号:
9340195 - 财政年份:2016
- 资助金额:
$ 19.14万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular genetics of human age-related hearing loss
人类年龄相关性听力损失的分子遗传学
- 批准号:
10637870 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Novel mechanism for sex differences in hearing loss
听力损失性别差异的新机制
- 批准号:
10659402 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Generation and Characterization of Novel Large Animal Models of Usher Syndrome Type 3
3 型亚瑟综合症新型大型动物模型的生成和表征
- 批准号:
10706969 - 财政年份:2022
- 资助金额:
$ 19.14万 - 项目类别:
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease
CYCLE-AD:评估室内骑行对有阿尔茨海默病遗传风险的健康老年人延缓疾病进展的功效的随机对照试验
- 批准号:
10328952 - 财政年份:2021
- 资助金额:
$ 19.14万 - 项目类别: